Does NINTEDANIB ESYLATE Cause Mobility decreased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Mobility decreased have been filed in association with NINTEDANIB ESYLATE (Ofev). This represents 4.3% of all adverse event reports for NINTEDANIB ESYLATE.
5
Reports of Mobility decreased with NINTEDANIB ESYLATE
4.3%
of all NINTEDANIB ESYLATE reports
5
Deaths
0
Hospitalizations
How Dangerous Is Mobility decreased From NINTEDANIB ESYLATE?
Of the 5 reports, 5 (100.0%) resulted in death, and 5 (100.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NINTEDANIB ESYLATE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does NINTEDANIB ESYLATE Cause?
Diarrhoea (54)
Nausea (24)
Decreased appetite (20)
Fatigue (20)
Vomiting (20)
Dyspnoea (18)
Weight decreased (17)
Off label use (16)
Constipation (13)
Dizziness (13)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which NINTEDANIB ESYLATE Alternatives Have Lower Mobility decreased Risk?
NINTEDANIB ESYLATE vs NIRAPARIB
NINTEDANIB ESYLATE vs NIRMATRELVIR\RITONAVIR
NINTEDANIB ESYLATE vs NIROGACESTAT
NINTEDANIB ESYLATE vs NIROGACESTAT HYDROBROMIDE
NINTEDANIB ESYLATE vs NIRSEVIMAB